静脉注射哈洛佩里多尔,兴奋和QTc:误解和启发方法
Erik Levinsohn1,2, Varsha Radhakrishnan3,4, Sunita Singh3,4
1From University of California San Francisco School of Medicine (Dr. Levinsohn).
Harvard review of psychiatry
|March 6, 2026
概括
精神病医生应避免使用纠正的QT (QTc) 截止值来进行静脉注射哈洛佩里多尔 (IVH) 的安全决定. 这种做法是一种不合适的启发式,而不是风险效益分析,目前的证据不支持在管理煽动时使用它.
科学领域:
- 临床药理学 临床药理学
- 心脏病学 心脏病学
- 精神病学是一个精神病学.
背景情况:
- 医生经常在复杂的临床决策中使用启发式分析.
- 由于QTc延长和Torsades de Pointes (TdP) 的风险,静脉利醇 (IVH) 的安全性经常受到质疑.
- 2007年FDA发布的警告加剧了人们对IVH和TdP风险的担忧.
研究的目的:
- 反对使用修正的QT (QTc) 截止值来证明IVH安全性.
- 重新评估IVH在急性兴奋管理中的临床决策过程.
- 解决将IVH,QTc和TdP联系在一起的误解.
主要方法:
- 分析临床实践和当前证据的视角作品.
- 审查IVH,QTc间隔和TdP之间的关系.
- 在临床环境中讨论启发式决策.
主要成果:
- 使用QTc截止值代表了一个不适当的启发式,而不是风险-收益评估.
- 目前对IVH,QTc和TdP的理解不支持使用QTc切线值.
- 关于IVH,QTc和TdP的误解在临床实践中仍然存在.
结论:
- 对IVH使用的决策过程进行重构对于改善患者护理至关重要.
- 临床医生应该超越简单的启发式方法,比如用于IVH风险评估的QTc切断值.
- 基于证据的风险效益分析应指导IVH在治疗急性动时的使用.
相关概念视频
Parenteral Anesthetics: Overview
844
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
844
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
734
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
734
Depolarizing Blockers: Pharmocokinetics
678
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
678
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
2.8K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.8K
Depolarizing Blockers: Mechanism of Action
3.2K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
3.2K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
2.5K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.5K


